331 – 340 of 466
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Measurement of the noncomplexed free fraction of tissue inhibitor of metalloproteinases I in plasma by immunoassay
Holten-Andersen, MN ; Christensen, IJ ; Nielsen, HJ ; Lilja, Hans LU
; Murphy, G
; Jensen, V
; Brunner, N
and Piironen, T
(2002)
In Clinical Chemistry
48(8).
p.1305-1313
- Contribution to journal › Article
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
Steuber, T ; Nurmikko, P ; Haese, A ; Pettersson, K ; Graefen, M ; Hammerer, P ; Huland, H and Lilja, Hans LU
(2002)
In Journal of Urology
168(5).
p.1917-1922
- Contribution to journal › Article
-
Mark
Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease
Ylikoski, A ; Pettersson, K ; Nurmi, J ; Irjala, K ; Karp, M ; Lilja, Hans LU
; Lovgren, T
and Nurmi, M
(2002)
In Clinical Chemistry
48(8).
p.1265-1271
- Contribution to journal › Article
-
Mark
Prediction of tumor heterogeneity in localized prostate cancer
Huland, H ; Graefen, M ; Haese, A ; Hammerer, PG ; Palisaar, J ; Pichlmeier, U ; Henke, RP ; Erbersdobler, A ; Huland, E and Lilja, Hans LU
(2002)
In Urologic Clinics of North America
29(1).
p.213-213
- Contribution to journal › Article
-
Mark
Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer
Holten-Andersen, MN ; Christensen, IJ ; Nielsen, HJ ; Stephens, RW ; Jensen, V ; Nielsen, OH ; Sorensen, S ; Overgaard, J ; Lilja, Hans LU
and Harris, A
, et al.
(2002)
In Clinical Cancer Research
8(1).
p.156-164
- Contribution to journal › Article
-
Mark
Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
Cao, Yue LU ; Lundwall, Åke LU ; Gadaleanu, Virgil ; Lilja, Hans LU
and Bjartell, Anders
LU
(2002)
In American Journal of Pathology
161(6).
p.2053-2063
- Contribution to journal › Article
-
Mark
Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step
Niemela, P ; Lovgren, J ; Karp, M ; Lilja, Hans LU
and Pettersson, K
(2002)
In Clinical Chemistry
48(8).
p.1257-1264
- Contribution to journal › Article
-
Mark
Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
Nurmikko, Pauliina ; Steuber, Thomas ; Haese, Alexander ; Pettersson, Kim ; Hammerer, Peter ; Huland, Hartwig and Lilja, Hans LU
(2002)
In Journal of Clinical Ligand Assay
25(1).
p.67-69
- Contribution to journal › Article
- 2001
-
Mark
Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues
Björk, Thomas LU ; Schalken, Jack ; Wittjes, Wim ; Ljungberg, Bengt LU and Lilja, Hans LU
(2001)
In The Prostate
47(1).
p.14-20
- Contribution to journal › Article
-
Mark
Activation of latent protease function of pro-hK2, but not pro-PSA, involves autoprocessing
Denmeade, Samuel R. ; Lövgren, Janita LU ; Khan, Saeed R. ; Lilja, Hans LU
and Isaacs, John T.
(2001)
In The Prostate
48(2).
p.122-126
- Contribution to journal › Article